Neurobiological Technologies, Inc.
Other OTCTotal Valuation
Neurobiological Technologies, Inc. carries a market capitalization of 2,702.00, placing it among publicly traded companies globally.
| Market Cap | 2,702.00 |
| Enterprise Value | N/A |
Share Statistics
Neurobiological Technologies, Inc. currently has 26.93M shares outstanding.
| Shares Outstanding | 26.93M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Neurobiological Technologies, Inc. trades at a trailing price-to-earnings ratio of 2.15. The price-to-sales ratio is 0.84, and the price-to-book ratio stands at -0.21.
| PE Ratio | 2.15 |
| PS Ratio | 0.84 |
| PB Ratio | -0.21 |
| P/TBV Ratio | 0.84 |
| P/FCF Ratio | -2.19 |
| P/OCF Ratio | -2.19 |
Financial Position
Neurobiological Technologies, Inc. maintains a current ratio of 45.33, meaning it holds 45.3x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 45.33 |
| Quick Ratio | 45.02 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | 32.67 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | -9.22 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Taxes
Over the trailing twelve months, Neurobiological Technologies, Inc. has paid 96,000.00 in income taxes, reflecting an effective tax rate of 1.75.
| Income Tax | 96,000.00 |
| Effective Tax Rate | 1.75 |
Stock Price Statistics
Neurobiological Technologies, Inc.'s stock has gained approximately 0.000003% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.00.
| Beta (5Y) | N/A |
| 52-Week Price Change | 0.000003% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Neurobiological Technologies, Inc. generated 28.81M in revenue and converted that into 11.29M in net income, yielding earnings per share of 0.42. EBITDA reached 12.15M, while operating income came in at 12.05M.
| Revenue | 28.81M |
| Gross Profit | 25.32M |
| Operating Income | 12.05M |
| Pretax Income | 5.50M |
| Net Income | 11.29M |
| EBITDA | 12.15M |
| EBIT | 12.05M |
| Earnings Per Share (EPS) | 0.42 |
Balance Sheet
Total book value stands at -117.04M, with working capital of 29.04M providing operational flexibility.
| Cash & Cash Equivalents | 26.49M |
| Total Debt | N/A |
| Net Debt | -9.58M |
| Equity (Book Value) | -117.04M |
| Book Value Per Share | -4.35 |
| Working Capital | 29.04M |
Cash Flow
Neurobiological Technologies, Inc. produced -11.06M in operating cash flow over the past twelve months.
| Operating Cash Flow | -11.06M |
| Capital Expenditures | N/A |
| Free Cash Flow | -11.06M |
| FCF Per Share | -0.41 |
Margins
Neurobiological Technologies, Inc. operates with a gross margin of 100.00, reflecting its pricing power and cost economics. The operating margin of 41.82 and net profit margin of 39.19 provide insight into operational efficiency.
| Gross Margin | 100.00 |
| Operating Margin | 41.82 |
| Pretax Margin | 19.09 |
| Profit Margin | 39.19 |
| EBITDA Margin | 42.16 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 0.00 |
| FCF Yield | -45.63 |
Stock Splits
Neurobiological Technologies, Inc.'s most recent stock split took place on September 17, 2007 with a 7:1 split ratio.
| Last Split Date | 9/17/2007 |
| Split Ratio | 7:1 |
Scores
Neurobiological Technologies, Inc. posts an Altman Z-Score of 20.17, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 20.17 |